To bleed or not to bleed: Identifying the clinical significance of platelet function abnormalities in myelodysplastic syndrome (MDS)

被引：0
|
作者：
Sellors, A. [1 ]
Gooding, R. [1 ]
机构：
[1] Univ Hosp Leicester NHS Trust, Dept Haematol, Leicester, Leics, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2016年 / 173卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
327
引用
收藏
页码：133 / 134
页数：2
相关论文
共 50 条
  • [1] Platelet function and its clinical significance in the myelodysplastic syndromes
    Zeidman, A
    Sokolover, N
    Fradin, Z
    Cohen, A
    Redlich, O
    Mittelman, M
    HEMATOLOGY JOURNAL, 2004, 5 (03) : 234 - 238
  • [2] PLATELET-FUNCTION IN MYELODYSPLASTIC SYNDROMES (MDS)
    PAMPHILON, DH
    ROBERTS, BE
    DAVIES, JA
    BRITISH JOURNAL OF HAEMATOLOGY, 1983, 55 (01) : 188 - 188
  • [3] Gastrointestinal Bleed in Patients With History of Myelodysplastic Syndrome: Inpatient Mortality Increased in Patients With Malnutrition
    Bhagat, Umesh
    Recinos, Luisa
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S289 - S290
  • [4] Why do patients with antiphospholipid syndrome bleed? A clinical paradox
    Fuentes-Lacouture, Maria Cynthia
    Gomez, Lizeth Bustamante
    Torres, Nicolas
    Arteaga-Unigarro, Carlos
    BLOOD COAGULATION & FIBRINOLYSIS, 2023, 34 (05) : 257 - 262
  • [5] Abnormalities of the bone marrow (BM) microenvironment in the myelodysplastic syndrome (MDS).
    Silverman, LR
    Zinzar, S
    Cuttner, J
    Holland, JF
    BLOOD, 1995, 86 (10) : 3194 - 3194
  • [6] Clinical Significance of Additional Cytogenetic Abnormalities (ACA) at Disease Progression in Patients with High-Risk Myelodysplastic Syndrome (MDS) Treated with Azacitidine
    Naito, Chiaki
    Shimizu, Hiroaki
    Miyazawa, Yuri
    Ishizaki, Takuma
    Yokohama, Akihiko
    Saito, Takayuki
    Tsukamoto, Norifumi
    Handa, Hiroshi
    BLOOD, 2019, 134
  • [7] CLINICAL EFFECTS OF DECITABINE IN MYELODYSPLASTIC SYNDROME (MDS)
    Golenkov, A. K.
    Dudina, G. A.
    Buravtsova, I. V.
    Oparina, N. V.
    Katayeva, E. V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 537 - 537
  • [8] CLINICAL COURSE AND TREATMENT OF MYELODYSPLASTIC SYNDROME (MDS)
    DONHUIJSENANT, R
    FUCHS, R
    SCHROEDER, M
    WESTERHAUSEN, M
    BLUT, 1988, 56 (06): : C15 - C15
  • [9] Phenotypic aberrations of myeloid CD34+cells in patients with myelodysplastic syndrome (MDS):: Clinical significance and correlation with cytogenetics abnormalities.
    Subira, D
    Font, P
    Arranz, E
    Ramiro, S
    Castanon, S
    Renedo, M
    Blas, C
    Garcia, MF
    Gonzalez, O
    Tomas, JF
    Fernandez-Rañada, JM
    BLOOD, 2004, 104 (11) : 652A - 652A
  • [10] Can platelet function testing tell whether your patient will bleed or thrombose?
    Lordkipanidze, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 46 - 46
12345